NuVasive, a medical device company developing treatment for minimally invasive spine surgery, has initiated a patent infringement lawsuit against Globus Medical regarding lateral fusion technology, according to a NuVasive news release.
NuVasive contends that Globus Medical's LLIF lateral fusion offering — including instrumentation, implants and techniques under the trademarks of TransContinental, MARS 3V and LLIF — infringe on NuVasive's XLIF intellectual property. The XLIF is a procedure for minimally invasive lumbar fusions.
Globus Medical has not responded to the NuVasive lawsuit.
Read the NuVasive release on patent infringement.
Read other coverage on NuVasive:
- Two Insurers Reverse Policies to Cover Procedures
- NuVasive Reports 2Q Revenue Up 35.2%
- Vail-Summit Spine Surgoen First to Use MAS-TLIF for Minimally Invasive Spine Fusion
NuVasive contends that Globus Medical's LLIF lateral fusion offering — including instrumentation, implants and techniques under the trademarks of TransContinental, MARS 3V and LLIF — infringe on NuVasive's XLIF intellectual property. The XLIF is a procedure for minimally invasive lumbar fusions.
Globus Medical has not responded to the NuVasive lawsuit.
Read the NuVasive release on patent infringement.
Read other coverage on NuVasive:
- Two Insurers Reverse Policies to Cover Procedures
- NuVasive Reports 2Q Revenue Up 35.2%
- Vail-Summit Spine Surgoen First to Use MAS-TLIF for Minimally Invasive Spine Fusion